Skip to search formSkip to main contentSkip to account menu

Prothrombin

Known as: Prothrombin [Chemical/Ingredient], Differentiation Reversal Factor, Factor II, Coagulation 
A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa… 
National Institutes of Health

Related topics

Related topics

47 relations
Activated Partial Thromboplastin Time measurementBlood coagulationCerebrovascular accidentCoagulants

Broader (3)

Blood Coagulation FactorEnzyme InhibitorsEnzyme Precursors

Narrower (17)

Factor IIaKcentraacarboxy prothrombinacetylcysteinyl-leucyl-glutamyl-glutamyl-prolyl-cysteine methyl ester cyclic disulfide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Factor V G 1691 A and prothrombin G 20210 A gene polymorphisms among Iranian patients with cerebral venous thrombosis
Objective: Cerebral venous thrombosis (CVT) is an important cause of stroke, especially in young adults, that has many… 
2011
2011
[Association of hemostatic disorders in diabetic patients with methylenetetrahydrofolate reductase (C677T) and coagulation factors II (G20210A) and V (G1691A) gene polymorphism].
The purpose of the investigation was to study an association of hemostatic disorders in diabetic patients with… 
2008
2008
Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation
Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and… 
2007
2007
Neonatal antiphospholipid syndrome associated with heterozygous methylentetrahydrofolate reductase C 677 T and prothrombin G 20210 A gene mutations
according to Chisholm and Mason [5]. A diagnosis of primary Sjögren’s syndrome was made according to the revised European… 
2004
2004
Prothrombin 20210 GA and Factor V Leiden Mutations in Patients Less Than 55 Years Old With Myocardial Infarction
Several studies claim that prothrombin 20210GA and factor V Leiden mutations are related to arterial thrombosis. We investigated… 
2003
2003
High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon.
High prevalence of prothrombin G20210A mutation among patients with deep venous thrombosis in Lebanon - 
2000
2000
The Factor V Leiden and Prothrombin G20210A Mutations in Kirghiz Population
Ñ~ãáäó ïáíÜçìí ÅäáåáÅ~ä ã~åáÑÉëí~íáçåë çÑ îÉåçìë íÜêçãÄçÉãÄçäáëãK e~Éã~íçäçÖáÅ~ NVVVX UQW SOTJPOK SK j~âêáë jI mêÉëíçåI cbI _… 
2000
2000
Incidence of Factor V Leiden and prothrombin G20210A in patients submitted to stem cell transplantation.
Factor V Leiden (FVL) and prothrombin G20210A are the most common defects associated with thrombophilia. The purpose of our study… 
2000
2000
A boy with venous thrombosis, homozygous for factor V Leiden, prothrombin G20210A and MTHFR C667t mutations, but belonging to an asymptomatic family.
We evaluated a 9-year old boy presenting with deep venous thrombosis who was homozygous for factor V Leiden, prothrombin 2021 OA… 
1999
1999
Prothrombin G20210A Gene Mutation and Further Prothrombotic Risk Factors in Childhood Thrombophilia
Abstract—Risk factors for venous thrombosis in adults are the prothrombin G20210A and the factor V (FV) G1691A mutations and…